CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2137
Detailed information
CancerLivER ID2137
Biomarker elF5A2
Biomarker Name/Symbol (given in Publication)elF5A2
BiomoleculeProtein
SubjectHuman
Degree of Validityuseful markers to evaluate the size and prognosis of liver cancer; but not validated on independent dataset
Experimental ConditionNormal vs HCC; predict survival of patients
Cancer typeHepatocellular carcinoma
RegulationUpregulated in paracancerous than in cancerous liver tissue
Level of significance p < 0.0001
SourceTissue
PMID23251252
Type of BiomarkerPrognostic
PathwayTGFβ signaling pathway
Cohort280 patients with HCC who underwent surgery to remove liver cancer between 2005 and 2011 in our hospital (Fudan University, Shanghai, China).
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseHuman HCC
Year of Publication2013
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top